Related references
Note: Only part of the references are listed.Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
Aaron Kruse et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The landscape of chromothripsis across adult cancer types
Natalia Voronina et al.
NATURE COMMUNICATIONS (2020)
Molecular markers in ALL: Clinical implications
Shunsuke Kimura et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2020)
Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression
Jian Han et al.
SCIENCE ADVANCES (2020)
Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia
Joanna Zawitkowska et al.
SCIENTIFIC REPORTS (2020)
Minimal residual disease in acute lymphoblastic leukemia: technical aspects and implications for clinical interpretation
In-Suk Kim
BLOOD RESEARCH (2020)
Uridine-cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancer
Yingjie Wu et al.
CANCER SCIENCE (2019)
Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort
Marketa Zaliova et al.
HAEMATOLOGICA (2019)
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL
Lina Hamadeh et al.
BLOOD ADVANCES (2019)
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
I. S. Jerchel et al.
LEUKEMIA (2018)
IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
Martin Stanulla et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia
David O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Integrative genomic and transcriptomic analysis of leiomyosarcoma
Priya Chudasama et al.
NATURE COMMUNICATIONS (2018)
Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors
Manasi Ratnaparkhe et al.
NATURE COMMUNICATIONS (2018)
Genetics and prognosis of ALL in children vs adults
Kathryn G. Roberts
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia
Marcin Braun et al.
LEUKEMIA & LYMPHOMA (2017)
Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia
Judith M. Boer et al.
ONCOTARGET (2017)
Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis
M. Ratnaparkhe et al.
LEUKEMIA (2017)
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia
Riadh Lobbardi et al.
CANCER DISCOVERY (2017)
Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia
R. Marke et al.
LEUKEMIA (2016)
New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia
Anthony V. Moorman
HAEMATOLOGICA (2016)
Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group
Rob Pieters et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia
Anthony V. Moorman
HAEMATOLOGICA (2016)
Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia
Veronica Leoni et al.
HAEMATOLOGICA (2015)
Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
Ute Fischer et al.
NATURE GENETICS (2015)
Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia
Veronica Leoni et al.
HAEMATOLOGICA (2015)
Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance
Ingrid M. Aries et al.
HAEMATOLOGICA (2015)
Outcomes of Children With BCR-ABL1-Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease
Kathryn G. Roberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Criteria for Inference of Chromothripsis in Cancer Genomes
Jan O. Korbel et al.
CELL (2013)
Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features
Claire J. Schwab et al.
HAEMATOLOGICA (2013)
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
Tobias Rausch et al.
CELL (2012)
Minimal residual disease monitoring in childhood acute lymphoblastic leukemia
Dario Campana
CURRENT OPINION IN HEMATOLOGY (2012)
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
T. Kalina et al.
LEUKEMIA (2012)
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
Philip J. Stephens et al.
CELL (2011)
Prognostic impact of t(1;19)/TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Munster-based protocols
Maria S. Felice et al.
LEUKEMIA & LYMPHOMA (2011)
Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow
Giuseppe Basso et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3
Josef Davidsson et al.
HUMAN MOLECULAR GENETICS (2007)
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting
V. H. J. van der Velden et al.
LEUKEMIA (2007)
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data
V. H. J. van der Velden et al.
LEUKEMIA (2007)